| Part Of Safety of Arthritis Drugs, Day 1,
Report Video IssueSafety of Arthritis Drugs, Day 1, Part 3
2005-02-24T02:19:52-05:00https://ximage.c-spanvideo.org/eyJidWNrZXQiOiJwaWN0dXJlcy5jLXNwYW52aWRlby5vcmciLCJrZXkiOiJGaWxlc1wvNWZlXC8yMDA1MDIyNDAzMjAwNzAwMV9oZC5qcGciLCJlZGl0cyI6eyJyZXNpemUiOnsiZml0IjoiY292ZXIiLCJoZWlnaHQiOjUwNn19fQ==Dr. Villalba and others spoke at a meeting to assess the safety records of arthritis drugs. They talked about testing and approval of the drug Vioxx and its subsequent use by American consumers. They also responded to questions from members of the committee and the audience.
A joint meeting of the Food and Drug Administration’s Arthritis and Drug Safety and Risk Management Advisory Committees held a forum on the safety of “COX-2” inhibitors. The function of the advisory committee was to provide advice and recommendations to the FDA on regulatory issues.
A joint meeting of the Food and Drug Administration’s Arthritis and Drug Safety and Risk Management Advisory Committees held a forum on the safety of “COX-2” inhibitors. The function of the advisory committee was to provide advice and recommendations to the FDA on regulatory issues.
Dr. Villalba and others spoke at a meeting to assess the safety records of arthritis drugs. They talked about testing and approval of the dr… read more
Dr. Villalba and others spoke at a meeting to assess the safety records of arthritis drugs. They talked about testing and approval of the drug Vioxx and its subsequent use by American consumers. They also responded to questions from members of the committee and the audience.
A joint meeting of the Food and Drug Administration’s Arthritis and Drug Safety and Risk Management Advisory Committees held a forum on the safety of “COX-2” inhibitors. The function of the advisory committee was to provide advice and recommendations to the FDA on regulatory issues. close
People in this video
Hosting Organization
More Videos From
Safety of Arthritis Drugs, Day 1,
More Videos
Purchase a Download
Safety of Arthritis Drugs, Day 1, Part 3
-
MP3 audio - Standard
- Price:
- $0.99
Related Video
-
Safety of Arthritis Drugs, Day 1, Part 2
A joint meeting of the Food and Drug Administration’s Arthritis and Drug Safety and Risk Management Advisory Committees …
-
Safety of Arthritis Drugs, Day 2, Part 1
Physicians spoke at a meeting to assess the safety records of arthritis drugs. Representatives for the drug Arcoxia and …
-
Drug Approval Process
Sidney Wolfe of Public Citizen, talked about the drug safety review and approval process, recent hearings on pharmaceuti…
-
Open Phones
Telephone lines were open for viewer comments on the question, “Should painkiller Celebrex be pulled from the market?”
User Created Clips from This Video
-
- 50 seconds
- 58 views
-
- 34 seconds
- 16 views